Recent news on Ciprofloxacin Hydrochloride

Depomed to Present at the Bank of America 2007 Healthcare Conference  -  May 22, 2007
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary

Depomed to Announce First Quarter 2007 Financial Results on ...  -  Apr 25, 2007
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary

Depomed Completes $20 Million Registered Direct Offering  -  Apr 23, 2007
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary

Depomed to Present at the CIBC World Markets Annual Biotechnology ...  -  Apr 4, 2007
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary

Depomed Appoints David Zenoff to Board of Directors  -  Mar 23, 2007
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary

Depomed Reports 2006 Year End Financial Results  -  Mar 14, 2007
Genetic Engineering News (press release),Of the total revenue recognized in 2006, $1.3 million was in product sales revenue from the commercial supply of ProQuin(R) XR (ciprofloxacin hydrochloride)

Depomed to Announce Fourth Quarter and Year End 2006 Financial ...  -  Feb 28, 2007
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary

Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug ...  -  Feb 12, 2007
CNW Telbec (Communiqués de presse),ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary

Depomed Receives $10 Million License Fee from Esprit and Withdraws ...  -  Dec 22, 2006
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary

Depomed Receives $10 Million License Fee from Esprit and Withdraws ...  -  Dec 22, 2006
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary

Depomed Reports Third Quarter 2006 Financial Results  09 Nov 2006
ProQuin® XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary tract ... -Business Wire (press release), Depomed to Present at the UBS Global Life Sciences Conference  Sep 20, 2006
ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary tract ... -Business Wire

Patheon breaks into drug delivery  Aug 29, 2006
...because it is used in two of Depomed's products it manufactures; ProQuin XR, a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the ... -In-PharmaTechnologist.com

Depomed Announces Equity Financing Commitment of Up to $30 Million  -  12 Dec 2006
Business Wire (press release),ProQuin® XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary tract

Depomed Comments on Today's Trading Activity  -  Dec 5, 2006
PharmaLive.com (press release),ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary

Patheon breaks into drug delivery  29 Aug 2006
...because it is used in two of Depomed's products it manufactures; ProQuin XR, a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the ... -In-PharmaTechnologist.com

TODAY ON PHARMALIVE.COM  Aug 23, 2006
ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary tract ... -PharmaLive.com

Depomed Announces Completion of Phase I Clinical Trial With ...  Aug 15, 2006
ProQuin(R) XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary tract ... -Business Wire

Mixed thoughts on how generic clopidogrel might impact patients ...  Aug 11, 2006
...disputes against other major pharmaceutical companies and gone on to produce and sell generic versions of Cipro (ciprofloxacin hydrochloride), Paxil (paroxetine ... -TheHeart.Org

Depomed to Present at the Bank of America Specialty ...  Jul 28, 2006
Proquin(R) XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary tract ... -Genetic Engineering News

Depomed Unveils Data at the Endocrine Society Meeting Showing ...  Jun 29, 2006
ProQuin(R) XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary tract ... -Genetic Engineering News

King Pharmaceuticals and Depomed Announce Agreement to Co-Promote ...  Jun 28, 2006
ProQuin(R) XR(ciprofloxacin hydrochloride) once daily, extended-release tabletshave been approved by the FDA for the treatment of uncomplicatedurinary tract ... -Finanzen.net



Depomed and Esprit Announce Availability of ProQuin XR ...  Apr 26, 2006
...announced today that Once-Daily ProQuin(R) XR, the new, prolonged release once-daily formulation of ciprofloxacin hydrochloride for the treatment of ... - DG News

Depomed Reports First Quarter 2006 Financial Results  May 10, 2006
Proquin(R) XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary tract ... - Genetic Engineering News





Depomed and Madaus Srl Announce Acceptance of the Application for ...  Mar 29, 2006
...infections. ProQuin XR is a once-daily, prolonged release formulation of ciprofloxacin hydrochloride, which was developed by Depomed. ... - Genetic Engineering News

Depomed to Present at CIBC Annual Biotechnology and Specialty ...  Mar 30, 2006
ProQuin(R) XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary tract ... - Genetic Engineering News

Depomed Ans Madaus Srl MAA For ProQuin XR, Accepted By Medical ...  Mar 29, 2006
...uncomplicated urinary tract infections. ProQuin XR is a release formulation of ciprofloxacin hydrochloride, which was developed by Depomed. - Trading Markets

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional